logo
  • Cardiology, Diabetes & Nephrology
    • Cardiology, Diabetes & Nephrology at the Limits 2019
      • Introduction
      • Scientific Committee
      • Schedule
      • Programme
      • Venue
      • Hotel
      • Information
      • Express Interest
      • Supporters
      • CDNATL 2019: Login
    • Cardiology, Diabetes & Nephrology at the Limits – Brazil 2019
      • Introduction
      • Venue
      • Schedule
      • Programme
      • Hotel
      • Supporters
      • Express Interest
    • Hatter Horizon Series
    • The 18th Malvern Diabetic Foot Conference
    • Previous Events
      • CDNATL 2018
        • Introduction
        • Scientific Committee
        • Schedule
        • Programme
        • Venue
        • Hotel
        • Information
        • CME Accreditation
        • Conflict of Interest forms
        • Supporters
      • CDNATL 2017
      • CDNATL 2016
      • CDNATL 2015
      • CDNATL 2014
      • CDATL 2013
      • CDATL 2012
      • NATL 2012
      • CDATL 2011
      • CDATL 2010
      • NATL 2010
      • CATL 2009
      • NATL 2009
  • Oncology
    • UCL Frontiers of Oncology 2019
      • Haematology
      • Melanoma
      • Urology
      • Women’s Health
      • Lung Cancer
      • Gastrointestinal Oncology
      • Paediatric Oncology
      • Supporters
    • Previous Events
      • Accelerating Cancer Immunotherapy 2017
        • Introduction
        • Programme
        • Chairs
        • Venue
        • Sponsor Packages
        • Supporters
      • Oncology at the Limits 2017
        • Introduction
        • Chairs
        • Programme
        • Schedule
        • Venue
        • Hotel
        • Information
        • Supporters
        • OATL 2017: Login
      • OATL 2016
      • OATL 2015
      • OATL 2014
      • OATL 2012
      • OATL 2011
      • OATL 2010
  • Multiple Sclerosis
    • Multiple Sclerosis Nurses at the Limits 2019
      • Introduction
      • Express Interest in MSNATL 2020
      • Programme
      • Chairs
      • Venue
      • Hotel
      • Information
      • Conflict of Interest Forms
      • Supporters
    • Multiple Sclerosis at the Limits 2020
      • Introduction
      • Chairs
      • Schedule
      • Programme
      • Information
      • Venue
      • Hotel
      • Supporters
      • Express Interest
    • Previous Events
      • MSATL 2018: Introduction
        • MSATL 2018: Programme
        • MSATL 2018: Chairs
        • MSATL 2018: Schedule
        • MSATL 2018: Venue
        • MSATL 2018: Hotel
        • MSATL 2018: Information
        • MSATL 2018: CME Accreditation
        • MSATL 2018: Supporters
        • MSATL 2018: Conflict of Interest Forms
      • MSATL 2017: Introduction
        • MSATL 2017: Chairs
        • MSATL 2017: Schedule
        • MSATL 2017: Programme
        • MSATL 2017: Venue
        • MSATL 2017: Supporters
  • About
    • Academic Founders
    • Independence
    • The Lancet
    • Support & Sponsorship
    • Delegate Invitations
  • Register Interest
  • Archive
    • Multiple Sclerosis Nurses at the Limits 2019
    • Hatter Horizon Series 2018
    • Multiple Sclerosis at the Limits 2018
    • Cardiology, Diabetes & Nephrology at the Limits 2018
    • Hatter Horizon Series 2017
    • Accelerating Cancer Immunotherapy 2017
    • Oncology at the Limits 2017
  • Supporters: 2019

Monday 20th and Tuesday 21st November 2017
The Royal College of Physicians, London, UK

 


Chairs

Gavin Giovannoni
Professor Gavin Giovannoni
Chair of Neurology,
Barts and The London School
of Medicine and Dentistry,
London, UK
Professor William CarrollProfessor William Carroll
Clinical Professor of Neurology,
University of Western Australia; Consultant neurologist at the Perron Institute, Perth, Australia

Monday 20th November
From 08:00
Registration and Coffee
09:00
Introduction and Welcome from the Chairs
09:10
Cellular immunology and its relevance to MS
B-cells subsets and their role in MS
Professor Amit Bar-Or
Center for Neuroinflammation and Experimental Therapeutics, University of Pennsylvania, Philadelphia, PA USA
09:50
NK-cells as a therapeutic target in MS
Professor Dr Roland Martin
University of Zurich, Zurich, Switzerland
10:30
Coffee Break
10:55
Role of T-regs in the treatment of MS
Dr Joanne Jones
Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
11:35
B-cell induced autoimmunity
Dr Vijay K. Kuchroo
Brigham and Women's Hospital, Boston, MA, USA
12:15
Lunch
13:15
Progressive Multiple Sclerosis
Therapeutic lag in progressive MS trials
Professor Maria Pia Sormani
Department of Health Sciences, University of Genoa, Italy
13:55
How to define secondary progressive MS
Dr Tomas Kalincik
Melbourne Brain Centre, Royal Melbourne Hospital, Melbourne, Australia
14:35
Coffee Break
15:00
Energetics and its role in progressive MS
Dr Don Mahad
Anne Rowling Regenerative Neurology Clinic, The University of Edinburgh, Edinburgh, UK
15:40
The expanding MS lesion as a treatment target in MS
Dr Daniel Reich
Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA
16:20
Debate: "To B or not T-B: that is the question"; the key pathogenic cell in MS is a B-cell and is independent of antigen presentation to T-cells
For
Professor David Baker
Centre for Neuroscience and Trauma, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK
16:20
vs
Against
Prof. Dr. med. Heinz Wiendl
Department of Neurology Universität Münster, Albert-Schweitzer-Campus 1 Münster, Germany
17:00
Scientific sessions close
Tuesday 21st November
09:00
Progressive Multiple Sclerosis contd.
Motor-sensory prognostic paradox in MS
Professor Gavin Giovannoni
Barts and The London School of Medicine and Dentistry, London, UK
09:40
Disease improvement in progressive MS trials
Dr Bruce Cree
Department of Neurology, UCSF School of Medicine, San Francisco, CA, USA
10:20
Coffee Break
10:45
Epidemiology of Multiple Sclerosis
The case for EBV vaccination to prevent MS
Professor Alberto Ascherio
Department of Nutrition, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Cambridge, MA, USA
11:25
Vitamin D as a disease-modifying treatment for MS
Dr Joost Smolders
Canisius Wilhelmina Ziekenhuis Nijmegen, The Netherlands
12:05
Lunch
13:00
Epidemiology of Multiple Sclerosis contd.
Lifestyle & environmental factors and their interactions with multiple sclerosis risk genes
Professor Tomas Olsson
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
13:40
TNF-alpha and what it tells us about MS
Professor Lars Fugger
The Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK
14:20
Sex hormones in MS
Dr Riley Bove
UCSF School of Medicine, Department of Neurology, UCSF, San Francisco, CA, USA
15:00
Closing comments from Chairs

Cardiology, Diabetes & Nephrology at the Limits XXI
Monday 8th - Wednesday 10th April 2019
London, UK

Cardiology, Diabetes & Nephrology at the Limits Brazil
Friday 12th - Saturday 13th July 2019
São Paulo, Brazil

Hatter Horizon GP Meeting
Friday 1st November 2019
London, UK

Hatter Horizon Series
Monday 9th December 2019
London, UK

Multiple Sclerosis at the Limits
Thursday 23rd January – Friday 24th January 2020
London, UK

Multiple Sclerosis Nurses at the Limits
Friday 14th & Saturday 15th February 2020
London, UK

The 18th Malvern Diabetic Foot Conference
Wednesday 13th - Friday 15th May 2020
Malvern, UK

Frontiers of Oncology: Colorectal Cancer
February 2020
London, UK

Links

  • Contact
  • The Lancet
  • UCL
  • UCT
  • Yale Cancer Center
  • Brigham & Women’s Hospital

Policies

  • Medical Disclaimer
  • Disclosure
  • E-mail Policy
  • Privacy Policy
  • Anti-spam Policy
  • Disclaimer
  • External Links Policy
  • Terms Of Use

Support

The 'At the Limits' series is supported by sponsorship & grants from the pharmaceutical industry.

Copyright

Copyright © 2019 At the Limits Ltd.

Please note, places for At the Limits events can ONLY be reserved via this website. External sites such as ‘10times’ are not affiliated to these events and places cannot be reserved via their website.

RSS Feed

 Subscribe to Announcements

  • Contact
  • The Lancet
  • UCL
  • UCT
  • Yale Cancer Center
  • Brigham & Women’s Hospital
CyberChimps ©2019
This site uses cookies More info